abstract |
The present invention provides compositions comprising a mutant SDF-1 peptide that has been mutated to be resistant to digestion with a substrate cell-derived factor-1 (SDF-1) peptide or protease, but retains chemoattractant activity (e.g., Or a stem cell expressing such a peptide) is used to treat or ameliorate tissue damage. |